Skip to main content

Advertisement

Table 5 The relationship between macrophage inflammatory protein (MIP)-1α or MIP-1β and other cytokines

From: Decreased macrophage inflammatory protein (MIP)-1α and MIP-1β increase the risk of developing nasopharyngeal carcinoma

Marker MIP-1α MIP-1β
Case–control study Nested case–control study Case–control study Nested case–control study
ρ P ρ P ρ P ρ P
EGF 0.29 0.070 0.07 0.447 0.25 0.003 0.02 0.798
Eotaxin 0.29 < 0.001 0.25 0.007 0.24 0.003 0.22 0.018
GCSF 0.39 < 0.001 0.06 0.544 0.39 < 0.001 − 0.06 0.544
Fractalkine 0.24 0.004 0.05 0.636 0.37 < 0.001 0.15 0.134
IFN-γ 0.38 0.008 0.09 0.316 0.22 0.008 0.11 0.243
GRO 0.21 0.012 0.06 0.523 0.26 0.002 0.06 0.523
MDC 0.33 < 0.001 0.01 0.922 0.26 0.002 0.03 0.778
IL-1α 0.16 0.07 − 0.01 0.888 0.19 0.03 − 0.08 0.394
IL-7 0.27 0.001 0.08 0.411 0.30 < 0.001 − 0.015 0.875
IL-8 0.47 < 0.001 0.63 < 0.001 0.30 < 0.001 0.49 < 0.001
MCP-1 0.20 0.014 0.19 0.035 0.09 0.280 0.18 0.048
VEGF 0.20 0.017 0.09 0.348 0.37 < 0.001 0.13 0.165
  1. ρ Spearman’s correlation coefficient, MIP-1α macrophage inflammatory protein-1 alpha, MIP-1β macrophage inflammatory protein-1 beta, EGF epidermal growth factor, GCSF granulocyte colony-stimulating factor, IFN-γ interferon gamma, GRO growth-regulated oncogene, MDC macrophage-derived chemokine, IL-1α interleukin-1 alpha, IL-7 interleukin-7, IL-8 interleukin-8, MCP-1 monocyte chemotactic protein-1, VEGF vascular endothelial growth factor